Skip to main content
. 2020 Jul 27;31(2):178–186. doi: 10.1038/s41422-020-0375-9

Fig. 4. Potential predictors of response for immunotherapy in IM subtype of TNBC.

Fig. 4

a TOP2A mutation in PR and non-PR patients of arm C. b Relationship between TOP2A mutation and tumor remission rate of arm C. c The change of amino acid positions related to TOP2A mutations in non-PR patients of arm C.